Compare Stitch Fix Inc (SFIX) vs Tango Therapeutics Inc. (TNGX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Stitch Fix Inc vs Tango Therapeutics Inc. — how do they compare? Stitch Fix Inc trades at $2.38 (market cap $326.66M), while Tango Therapeutics Inc. trades at $22.23 (market cap $3.75B). The key difference: Tango Therapeutics Inc. is far larger — about 11.5× Stitch Fix Inc's market cap, and Tango Therapeutics Inc. is trading nearer its 52-week high, Stitch Fix Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Stitch Fix Inc for 31 Days and Tango Therapeutics Inc. for 0 Days on average.
| SFIX | TNGX | |
|---|---|---|
Market Cap | $326.66M | $3.75B |
Volume | 3,004,657 | 9,619,106 |
Sector | Consumer Cyclical | Health |
52-Week High | $5.64 | $32.90 |
52-Week Low | $2.16 | $7.50 |
Typical Hold Time | 31 Days | 0 Days |
Enterprise Value | $222.46M | $2.77B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Stitch Fix (SFIX) trades at $2.39, down 11.48% amid bearish technical signals and negative cash flow trends. The company shows improving fundamentals with three consecutive quarterly EPS beats and narrowing losses, though revenue remains stagnant at $1.27B. Recent news highlights fraud investigations and disappointing Q4 2026 results that missed revenue estimates, driving the stock's decline.
The outlook remains challenging with analyst consensus leaning neutral (69.7% hold) and a $3.40 price target suggesting limited upside. Key risks include ongoing legal scrutiny, weak FY27 guidance, and persistent net losses despite margin improvements. The stock's trajectory depends on reversing active client declines and achieving sustainable profitability.
TNGX trades at $22.22, down 8.07% in the last session, reflecting negative investor reaction to recent earnings misses. The stock shows neutral technical signals with key support at $21 and resistance at $23. Fundamentally, the company maintains a high gross margin of 98.25% but faces significant losses with a net income margin of -229.92% and negative cash flow from operations. Recent news highlights institutional buying interest and upcoming clinical trial developments.
Despite strong analyst support with a $45.91 consensus price target (107% upside), TNGX faces substantial execution risks as a clinical-stage biotech. The company's heavy cash burn and lack of profitability require careful monitoring of pipeline progress. Investment appeal hinges on successful drug development outcomes rather than current financial metrics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Stitch Fix Inc
Stitch Fix Inc offers personal style service for men and women. The company engages in delivering one-to-one personalization to clients through the combination of data science and human judgment. It provides a shipment service called A FIX where the stylist's hand selects items from several merchandises with analysis of client and merchandise data to provide a personalized shipment of apparel, shoes, and accessories suited to the client's needs. The company offers products across categories, brands, product types and price points including Women's, Petite, Maternity, Men's and Plus. It also offers various product types, including denim, dresses, blouses, skirts, shoes, jewelry and handbags, and sells merchandise across various range of price points.
Read more on SFIX →About Tango Therapeutics Inc.
Tango Therapeutics, Inc. is a clinical-stage biotechnology company focused on precision oncology, developing cancer therapies based on the genetic principle of synthetic lethality, including its PRMT5 inhibitor program.
Read more on TNGX →
